ArticleDiscover oncology2025

Identification of telomere maintenance-driven molecular subtypes in hepatocellular carcinoma: implications for prognosis and targeted therapy via KPNA2.

Zhicheng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.